Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
22.69
-0.26 (-1.13%)
Jun 3, 2026, 10:45 AM EDT - Market open
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.4 billion as of June 3, 2026. Its market cap has increased by 36,572.73% in one year.
Market Cap
1.40B
Enterprise Value
879.75M
1-Year Change
36,572.73%
Ranking
Category
Stock Price
$22.69
Market Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.40B, an increase of 278.72%. That is a compound annual growth rate of 26.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 1.41B | 3,743.48% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palvella Therapeutics | 1.61B |
| Innoviva | 1.59B |
| AnaptysBio | 1.55B |
| Vir Biotechnology | 1.52B |
| Immatics | 1.49B |
| Fortrea Holdings | 1.49B |
| Immunocore Holdings | 1.48B |
| Precigen | 1.47B |